A Novel NIR Fluorescent Nanoprobe Targeting HER2-Positive Breast Cancer: Tra-TTR-A
TTRE, a photosensitizer molecule, has excellent biofluorescence imaging performance and effective antitumor properties for breast cancer. However, its application in breast cancer treatment is limited due to poor tumor selectivity and lack of targeting ability. In this study, TTRE and trastuzumab we...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2021-01-01
|
Series: | Bioinorganic Chemistry and Applications |
Online Access: | http://dx.doi.org/10.1155/2021/2495958 |
_version_ | 1798034250789814272 |
---|---|
author | Meijuan Chen Zhousheng Lin Guangyu Yao Xi Hong Xiaolei Xue Lujia Chen |
author_facet | Meijuan Chen Zhousheng Lin Guangyu Yao Xi Hong Xiaolei Xue Lujia Chen |
author_sort | Meijuan Chen |
collection | DOAJ |
description | TTRE, a photosensitizer molecule, has excellent biofluorescence imaging performance and effective antitumor properties for breast cancer. However, its application in breast cancer treatment is limited due to poor tumor selectivity and lack of targeting ability. In this study, TTRE and trastuzumab were combined to synthesize Tra-TTR-A, a novel near-infrared fluorescent nanoprobe for HER2 positive breast cancer. The targeting and antitumor abilities of Tra-TTR-A in breast cancer were also investigated. Like TTRE, Tra-TTR-A has a stable structure with remarkable optical properties and in vivo imaging capacity. However, Tra-TTR-A not only inhibits tumor growth by generating reactive oxygen species but also kills tumor cells by trastuzumab. In this study, Tra-TTR-A, a new type of near-infrared fluorescent nanoprobe that targets HER2-positive breast cancer, was successfully synthesized. Tra-TTR-A could be used in in vivo imaging, targeted photodynamic therapy, and diagnosis and treatment for breast cancer. |
first_indexed | 2024-04-11T20:41:46Z |
format | Article |
id | doaj.art-7ef2f4947bdc4b13b4a765ef21be72b4 |
institution | Directory Open Access Journal |
issn | 1687-479X |
language | English |
last_indexed | 2024-04-11T20:41:46Z |
publishDate | 2021-01-01 |
publisher | Hindawi Limited |
record_format | Article |
series | Bioinorganic Chemistry and Applications |
spelling | doaj.art-7ef2f4947bdc4b13b4a765ef21be72b42022-12-22T04:04:11ZengHindawi LimitedBioinorganic Chemistry and Applications1687-479X2021-01-01202110.1155/2021/2495958A Novel NIR Fluorescent Nanoprobe Targeting HER2-Positive Breast Cancer: Tra-TTR-AMeijuan Chen0Zhousheng Lin1Guangyu Yao2Xi Hong3Xiaolei Xue4Lujia Chen5State Key Laboratory of Organ Failure ResearchBreast CenterBreast CenterBreast CenterDepartment of PathologyBreast CenterTTRE, a photosensitizer molecule, has excellent biofluorescence imaging performance and effective antitumor properties for breast cancer. However, its application in breast cancer treatment is limited due to poor tumor selectivity and lack of targeting ability. In this study, TTRE and trastuzumab were combined to synthesize Tra-TTR-A, a novel near-infrared fluorescent nanoprobe for HER2 positive breast cancer. The targeting and antitumor abilities of Tra-TTR-A in breast cancer were also investigated. Like TTRE, Tra-TTR-A has a stable structure with remarkable optical properties and in vivo imaging capacity. However, Tra-TTR-A not only inhibits tumor growth by generating reactive oxygen species but also kills tumor cells by trastuzumab. In this study, Tra-TTR-A, a new type of near-infrared fluorescent nanoprobe that targets HER2-positive breast cancer, was successfully synthesized. Tra-TTR-A could be used in in vivo imaging, targeted photodynamic therapy, and diagnosis and treatment for breast cancer.http://dx.doi.org/10.1155/2021/2495958 |
spellingShingle | Meijuan Chen Zhousheng Lin Guangyu Yao Xi Hong Xiaolei Xue Lujia Chen A Novel NIR Fluorescent Nanoprobe Targeting HER2-Positive Breast Cancer: Tra-TTR-A Bioinorganic Chemistry and Applications |
title | A Novel NIR Fluorescent Nanoprobe Targeting HER2-Positive Breast Cancer: Tra-TTR-A |
title_full | A Novel NIR Fluorescent Nanoprobe Targeting HER2-Positive Breast Cancer: Tra-TTR-A |
title_fullStr | A Novel NIR Fluorescent Nanoprobe Targeting HER2-Positive Breast Cancer: Tra-TTR-A |
title_full_unstemmed | A Novel NIR Fluorescent Nanoprobe Targeting HER2-Positive Breast Cancer: Tra-TTR-A |
title_short | A Novel NIR Fluorescent Nanoprobe Targeting HER2-Positive Breast Cancer: Tra-TTR-A |
title_sort | novel nir fluorescent nanoprobe targeting her2 positive breast cancer tra ttr a |
url | http://dx.doi.org/10.1155/2021/2495958 |
work_keys_str_mv | AT meijuanchen anovelnirfluorescentnanoprobetargetingher2positivebreastcancertrattra AT zhoushenglin anovelnirfluorescentnanoprobetargetingher2positivebreastcancertrattra AT guangyuyao anovelnirfluorescentnanoprobetargetingher2positivebreastcancertrattra AT xihong anovelnirfluorescentnanoprobetargetingher2positivebreastcancertrattra AT xiaoleixue anovelnirfluorescentnanoprobetargetingher2positivebreastcancertrattra AT lujiachen anovelnirfluorescentnanoprobetargetingher2positivebreastcancertrattra AT meijuanchen novelnirfluorescentnanoprobetargetingher2positivebreastcancertrattra AT zhoushenglin novelnirfluorescentnanoprobetargetingher2positivebreastcancertrattra AT guangyuyao novelnirfluorescentnanoprobetargetingher2positivebreastcancertrattra AT xihong novelnirfluorescentnanoprobetargetingher2positivebreastcancertrattra AT xiaoleixue novelnirfluorescentnanoprobetargetingher2positivebreastcancertrattra AT lujiachen novelnirfluorescentnanoprobetargetingher2positivebreastcancertrattra |